Cost-effectiveness analysis of treatment strategies initiating with second-generation antipsychotic long-acting injectables in patients with schizophrenia in the United States

Journal of Managed Care and Specialty Pharmacy · Published 2026-04-27 · DOI 10.18553/jmcp.2026.32.5.596

Free full text

Authors being retrieved — see the publisher record. https://doi.org/10.18553/jmcp.2026.32.5.596

Abstract

PubPorta does not have an abstract for this article yet.

Read the article at the publisher →

Publication details

Year
2026

Related articles